Page last updated: 2024-10-23

berberine and Arterial Occlusive Diseases

berberine has been researched along with Arterial Occlusive Diseases in 1 studies

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Berberine was found to inhibit platelet aggregation, superoxide production via modulating AR, NOX, and glutathione reductase activities in high glucose (HG) treated platelets."1.51Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. ( Girish, KS; Hemshekhar, M; Kemparaju, K; Paul, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paul, M1
Hemshekhar, M1
Kemparaju, K1
Girish, KS1

Other Studies

1 other study available for berberine and Arterial Occlusive Diseases

ArticleYear
Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity.
    Free radical biology & medicine, 2019, Volume: 130

    Topics: Aldehyde Reductase; Antioxidants; Apoptosis; Arterial Occlusive Diseases; Berberine; Blood Platelets

2019